Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Migraine

  Free Subscription


Articles published in Neurology

Retrieve available abstracts of 55 articles:
HTML format
Text format



Single Articles


    July 2019
  1. ARKINK EB, Palm-Meinders IH, Koppen H, Milles J, et al
    Microstructural white matter changes preceding white matter hyperintensities in migraine.
    Neurology. 2019 Jul 11. pii: WNL.0000000000007940.
    PubMed     Text format     Abstract available


  2. FORD JH, Ayer DW, Zhang Q, Carter JN, et al
    Two randomized migraine studies of galcanezumab: Effects on patient functioning and disability.
    Neurology. 2019 Jul 3. pii: WNL.0000000000007856.
    PubMed     Text format     Abstract available


    May 2019
  3. TU Y, Fu Z, Zeng F, Maleki N, et al
    Abnormal thalamo-cortical network dynamics in migraine.
    Neurology. 2019 May 10. pii: WNL.0000000000007607.
    PubMed     Text format     Abstract available


  4. COPPOLA G, Di Renzo A, Petolicchio B, Tinelli E, et al
    Aberrant interactions of cortical networks in chronic migraine: A resting-state fMRI study.
    Neurology. 2019 May 3. pii: WNL.0000000000007577.
    PubMed     Text format     Abstract available


    April 2019
  5. LIPTON RB, Tepper SJ, Reuter U, Silberstein S, et al
    Erenumab in chronic migraine: Patient-reported outcomes in a randomized double-blind study.
    Neurology. 2019 Apr 17. pii: WNL.0000000000007452.
    PubMed     Text format     Abstract available


  6. TEPPER SJ, Diener HC, Ashina M, Brandes JL, et al
    Erenumab in chronic migraine with medication overuse: Subgroup analysis of a randomized trial.
    Neurology. 2019 Apr 17. pii: WNL.0000000000007497.
    PubMed     Text format     Abstract available


  7. ONDERWATER GLJ, Ligthart L, Bot M, Demirkan A, et al
    Large-scale plasma metabolome analysis reveals alterations in HDL metabolism in migraine.
    Neurology. 2019 Apr 3. pii: WNL.0000000000007313.
    PubMed     Text format     Abstract available


    March 2019
  8. ALBRECHT DS, Mainero C, Ichijo E, Ward N, et al
    Imaging of neuroinflammation in migraine with aura: A [(11)C]PBR28 PET/MRI study.
    Neurology. 2019 Mar 27. pii: WNL.0000000000007371.
    PubMed     Text format     Abstract available


  9. FILIPPI M, Messina R, Goadsby PJ, Rocca MA, et al
    Author response: Gray matter volume modifications in migraine: A cross-sectional and longitudinal study.
    Neurology. 2019;92:587-588.
    PubMed     Text format    


  10. GUPTA VK
    Reader response: Gray matter volume modifications in migraine: A cross-sectional and longitudinal study.
    Neurology. 2019;92:587.
    PubMed     Text format    


  11. SIEGLER JE 3RD, Galetta S
    Editors' note: Gray matter volume modifications in migraine: A cross-sectional and longitudinal study.
    Neurology. 2019;92:586.
    PubMed     Text format    


  12. LAPUCCI C, Saitta L, Bommarito G, Sormani MP, et al
    How much do periventricular lesions assist in distinguishing migraine with aura from CIS?
    Neurology. 2019 Mar 8. pii: WNL.0000000000007266.
    PubMed     Text format     Abstract available


    February 2019
  13. DOMINGUEZ C, Lopez A, Ramos-Cabrer P, Vieites-Prado A, et al
    Iron deposition in periaqueductal gray matter as a potential biomarker for chronic migraine.
    Neurology. 2019 Feb 1. pii: WNL.0000000000007047.
    PubMed     Text format     Abstract available


    January 2019
  14. LEE MJ, Park BY, Cho S, Park H, et al
    Cerebrovascular reactivity as a determinant of deep white matter hyperintensities in migraine.
    Neurology. 2019 Jan 4. pii: WNL.0000000000006822.
    PubMed     Text format     Abstract available


    December 2018
  15. GELAYE B, Sacco S, Brown W, Nitchie H, et al
    Author response: Body composition status and the risk of migraine: A meta-analysis.
    Neurology. 2018;91:1074.
    PubMed     Text format    


  16. GUPTA VK
    Reader response: Body composition status and the risk of migraine: A meta-analysis.
    Neurology. 2018;91:1073.
    PubMed     Text format    


  17. LEWIS A, Galetta S
    Editors' note: Body composition status and the risk of migraine: A meta-analysis.
    Neurology. 2018;91:1073.
    PubMed     Text format    


    November 2018
  18. REISMAN AM, Robbins BT, Chou DE, Yugrakh MS, et al
    Ticagrelor for Refractory Migraine/Patent Foramen Ovale (TRACTOR): An open-label pilot study.
    Neurology. 2018;91:1010-1017.
    PubMed     Text format     Abstract available


  19. SOMMER RJ, Nazif T, Privitera L, Robbins BT, et al
    Retrospective review of thienopyridine therapy in migraineurs with patent foramen ovale.
    Neurology. 2018;91:1002-1009.
    PubMed     Text format     Abstract available


  20. DETKE HC, Goadsby PJ, Wang S, Friedman DI, et al
    Galcanezumab in chronic migraine: The randomized, double-blind, placebo-controlled REGAIN study.
    Neurology. 2018 Nov 16. pii: WNL.0000000000006640.
    PubMed     Text format     Abstract available


  21. KUCA B, Silberstein SD, Wietecha L, Berg PH, et al
    Lasmiditan is an effective acute treatment for migraine: A phase 3 randomized study.
    Neurology. 2018 Nov 16. pii: WNL.0000000000006641.
    PubMed     Text format     Abstract available


  22. FRIDMAN S, Sposato LA
    Migraine with visual aura, incident AF, and stroke risk: Is migraine with aura an embolic TIA?
    Neurology. 2018 Nov 14. pii: WNL.0000000000006637.
    PubMed     Text format    


  23. SEN S, Androulakis XM, Duda V, Alonso A, et al
    Migraine with visual aura a risk factor for incident atrial fibrillation: A cohort study.
    Neurology. 2018 Nov 14. pii: WNL.0000000000006650.
    PubMed     Text format     Abstract available


    August 2018
  24. VEREB D, Szabo N, Tuka B, Tajti J, et al
    Correlation of neurochemical and imaging markers in migraine: PACAP38 and DTI measures.
    Neurology. 2018 Aug 22. pii: WNL.0000000000006201.
    PubMed     Text format     Abstract available


  25. VANDERPLUYM J, Dodick DW, Lipton RB, Ma Y, et al
    Fremanezumab for preventive treatment of migraine: Functional status on headache-free days.
    Neurology. 2018 Aug 17. pii: 01.wnl.0000544321.19316.
    PubMed     Text format     Abstract available


    June 2018
  26. VAN OOSTERHOUT WPJ, Schoonman GG, van Zwet EW, Dekkers OM, et al
    Female sex hormones in men with migraine.
    Neurology. 2018 Jun 27. pii: WNL.0000000000005855.
    PubMed     Text format     Abstract available


  27. MESSINA R, Rocca MA, Colombo B, Pagani E, et al
    Gray matter volume modifications in migraine: A cross-sectional and longitudinal study.
    Neurology. 2018 Jun 20. pii: WNL.0000000000005819.
    PubMed     Text format     Abstract available


  28. TASSORELLI C, Grazzi L, de Tommaso M, Pierangeli G, et al
    Noninvasive vagus nerve stimulation as acute therapy for migraine: The randomized PRESTO study.
    Neurology. 2018 Jun 15. pii: WNL.0000000000005857.
    PubMed     Text format     Abstract available


  29. LIPTON RB, Goadsby PJ
    Comment: Noninvasive neurostimulation for migraine should be part of the general neurologist's therapeutic armamentarium.
    Neurology. 2018 Jun 15. pii: WNL.0000000000005870.
    PubMed     Text format    


    April 2018
  30. SCHULTE LH, Allers A, May A
    Visual stimulation leads to activation of the nociceptive trigeminal nucleus in chronic migraine.
    Neurology. 2018 Apr 27. pii: WNL.0000000000005622.
    PubMed     Text format     Abstract available


    March 2018
  31. EL YOUSSEF N, Maalouf N, Mourad A, Saade J, et al
    Teaching NeuroImages: Retinal migraine in action.
    Neurology. 2018;90:e992.
    PubMed     Text format    


    January 2018
  32. PELZER N, Haan J, Stam AH, Vijfhuizen LS, et al
    Clinical spectrum of hemiplegic migraine and chances of finding a pathogenic mutation.
    Neurology. 2018 Jan 17. pii: WNL.0000000000004966.
    PubMed     Text format     Abstract available


    November 2017
  33. KOWALEC K, McKay KA, Patten SB, Fisk JD, et al
    Comorbidity increases the risk of relapse in multiple sclerosis: A prospective study.
    Neurology. 2017 Nov 8. pii: 10.1212/WNL.0000000000004716.
    PubMed     Text format     Abstract available


    October 2017
  34. FRIEDMAN BW, Irizarry E, Solorzano C, Latev A, et al
    Randomized study of IV prochlorperazine plus diphenhydramine vs IV hydromorphone for migraine.
    Neurology. 2017 Oct 18. pii: 10.1212/WNL.0000000000004642.
    PubMed     Text format     Abstract available


  35. PALM-MEINDERS IH, Arkink EB, Koppen H, Amlal S, et al
    Volumetric brain changes in migraineurs from the general population.
    Neurology. 2017 Oct 11. pii: 10.1212/WNL.0000000000004640.
    PubMed     Text format     Abstract available


    August 2017
  36. FERRONI P, Barbanti P, Aurilia C, Egeo G, et al
    Procoagulant imbalance in premenopausal women with chronic migraine.
    Neurology. 2017 Aug 25. pii: 10.1212/WNL.0000000000004435.
    PubMed     Text format    


  37. ASHINA M, Dodick D, Goadsby PJ, Reuter U, et al
    Erenumab (AMG 334) in episodic migraine: Interim analysis of an ongoing open-label study.
    Neurology. 2017 Aug 23. pii: 10.1212/WNL.0000000000004391.
    PubMed     Text format     Abstract available


  38. BEAR JJ, Gelfand AA, Goadsby PJ, Bass N, et al
    Occipital headaches and neuroimaging in children.
    Neurology. 2017;89:469-474.
    PubMed     Text format     Abstract available


    July 2017
  39. MULLER KI, Alstadhaug KB, Bekkelund SI
    A randomized trial of telemedicine efficacy and safety for nonacute headaches.
    Neurology. 2017;89:153-162.
    PubMed     Text format     Abstract available


  40. SCHER AI, Buse DC, Fanning KM, Kelly AM, et al
    Comorbid pain and migraine chronicity: The Chronic Migraine Epidemiology and Outcomes Study.
    Neurology. 2017 Jul 5. pii: 10.1212/WNL.0000000000004177.
    PubMed     Text format     Abstract available


    June 2017
  41. ANDROULAKIS XM, Krebs K, Peterlin BL, Zhang T, et al
    Modulation of intrinsic resting-state fMRI networks in women with chronic migraine.
    Neurology. 2017 Jun 14. pii: 10.1212/WNL.0000000000004089.
    PubMed     Text format     Abstract available


  42. DE JONG HJI, Kingwell E, Shirani A, Cohen Tervaert JW, et al
    Evaluating the safety of beta-interferons in MS: A series of nested case-control studies.
    Neurology. 2017;88:2310-2320.
    PubMed     Text format     Abstract available


    April 2017
  43. SCHULTE LH, Allers A, May A
    Hypothalamus as a mediator of chronic migraine: Evidence from high-resolution fMRI.
    Neurology. 2017 Apr 26. pii: 10.1212/WNL.0000000000003963.
    PubMed     Text format     Abstract available


  44. GELAYE B, Sacco S, Brown WJ, Nitchie HL, et al
    Body composition status and the risk of migraine: A meta-analysis.
    Neurology. 2017 Apr 12. pii: 10.1212/WNL.0000000000003919.
    PubMed     Text format     Abstract available


    March 2017
  45. DASILVA AF, Nascimento TD, Jassar H, Heffernan J, et al
    Dopamine D2/D3 imbalance during migraine attack and allodynia in vivo.
    Neurology. 2017 Mar 29. pii: 10.1212/WNL.0000000000003861.
    PubMed     Text format     Abstract available


  46. MONTEITH TS
    Migraine relief: Nonpainful stimulation for acute attacks.
    Neurology. 2017;88:e128-e131.
    PubMed     Text format    


  47. YARNITSKY D, Volokh L, Ironi A, Weller B, et al
    Nonpainful remote electrical stimulation alleviates episodic migraine pain.
    Neurology. 2017 Mar 1. pii: 10.1212/WNL.0000000000003760.
    PubMed     Text format     Abstract available


    December 2016
  48. ANDROULAKIS XM, Kodumuri N, Giamberardino LD, Rosamond WD, et al
    Ischemic stroke subtypes and migraine with visual aura in the ARIC study.
    Neurology. 2016;87:2527-2532.
    PubMed     Text format     Abstract available


  49. SPOSATO LA, Peterlin BL
    Cardioembolism as the unsuspected missing link between migraine and ischemic stroke.
    Neurology. 2016;87:2504-2505.
    PubMed     Text format    


    November 2016
  50. SETHI M, Kowalczyk MA, Dalic LJ, Archer JS, et al
    Abnormal neurovascular coupling during status epilepticus migrainosus in Sturge-Weber syndrome.
    Neurology. 2016 Nov 30. pii: 10.1212/WNL.0000000000003492.
    PubMed     Text format    


  51. LOUTER MA, Pelzer N, de Boer I, Kuijvenhoven BE, et al
    Prevalence of lifetime depression in a large hemiplegic migraine cohort.
    Neurology. 2016 Nov 2. pii: 10.1212/WNL.0000000000003376.
    PubMed     Text format     Abstract available


    October 2016
  52. DESOUZA DD, O'Hare M, Woldeamanuel YW, Cowan RP, et al
    Journal Club: Change in brain network connectivity during PACAP38-induced migraine attacks.
    Neurology. 2016;87:e199-e202.
    PubMed     Text format    


  53. WOLDEAMANUEL YW, O'Hare M, DeSouza DD, Cowan RP, et al
    Journal Club: Exacerbation of headache during dihydroergotamine for chronic migraine does not alter outcome.
    Neurology. 2016;87:e196-e198.
    PubMed     Text format     Abstract available


  54. COPPOLA G, Di Renzo A, Tinelli E, Di Lorenzo C, et al
    Thalamo-cortical network activity during spontaneous migraine attacks.
    Neurology. 2016 Oct 14. pii: 10.1212/WNL.0000000000003327.
    PubMed     Text format     Abstract available


  55. VERSLEGERS WR, Leone M, Proietti Cecchini A
    Long-term use of daily sumatriptan injections in severe drug-resistant chronic cluster headache.
    Neurology. 2016;87:1522-1523.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Migraine is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: